The DEA recently announced the third extension of Covid-19 flexibilities for the virtual prescribing of controlled substances. Telehealth advocates applaud this move but remain hopeful for a more permanent solution in the future.
In a letter, several stakeholders urged the Drug Enforcement Administration to release a revised proposed rule on the virtual prescribing of controlled substances. This comes as Covid-19 flexibilities that allow controlled substances to be prescribed via telehealth without an in-person exam are set to expire at the end of the year.
Get your IV treatment from wherever you are. These top companies provide mobile IV therapy administered by experienced nurses in NYC and beyond.
Talkiatry, Array Behavioral Care, Iris Telehealth and Quartet Health sent a letter to the DEA asking for a special registration process that would allow for the prescribing of certain controlled medications via telemedicine.
The Drug Enforcement Administration received 38,000 comments on its proposed rule that would roll back Covid-19 flexibilities for the prescribing of controlled substances via telemedicine. In response, the DEA chose to temporarily extend the flexibilities, a decision telehealth companies like Bicycle Health and Mindbloom are in support of.
The American Medical Association recently released its comments on the DEA’s proposed rules for controlled substance prescribing via telemedicine. Many telehealth providers are supportive of the organization's recommendations, such as its suggestion to extend the timeframe patients have to refill their buprenorphine prescription after their initial supply is prescribed via telemedicine.
The DEA recently released proposed rules that would require an in-person visit before a patient can receive a telehealth prescription for a controlled substance. The DEA touts the change as a way to ensure patient safety, but several telehealth advocates argue it will greatly disrupt access for those who need the drugs — especially at a time when the mental health and substance use crisis is growing.
This report highlights what Paubox says is a broken infrastructure at the heart of this issue, exposing millions to preventable risks.
The Department of Justice filed a lawsuit against Rite Aid, accusing the pharmacy chain of filling hundreds of thousands of opioid prescriptions that had “obvious, and often multiple, red flags.” The DOJ claimed that Rite Aid violated the Controlled Substances Act by filling unlawful prescriptions for addictive drugs, as well as the False Claims Act when the chain sought reimbursement from federal healthcare programs for these prescriptions.
There are high levels of substance use and dangerous mental health stigma among healthcare workers, according to a report released by addiction treatment organization APN. Its CEO said the most effective way to decrease stigma about seeking mental health treatment is to look at healthcare as inclusive of mental health.
Through the Splunk controlled substance monitoring platform, NewYork-Presbyterian can see if medications are being diverted for potentially illegitimate purposes, like a doctor prescribing a medication to a patient not currently in the hospital.
The company's Individual Risk Identification Score, or IRIS, uses machine learning to help hospitals pinpoint employees who pose a high risk for drug diversion.
Who accredits health plans for mental health parity compliance? Learn about the only organization that offers this program to ensure your members get equitable care.
Since HealthEast Care System in St. Paul, Minnesota, became the first health system in the state to go live with EPCS two years ago, clinicians have saved an aggregate of about 500 hours per month in time spent writing prescriptions for controlled drugs, CHIME attendees heard Wednesday.
The new law will require prescribers and pharmacists to check the state's prescription monitoring program before prescribing or dispensing a controlled drug. It also limits the strength and duration of scripts for opioids.
The New York law is meant to cut down on prescription drug abuse and drug diversion by doctors and patients alike.
After a long battle, proponents of e-prescribing have achieved their goal of electronic prescribing of controlled substances becoming legal nationwide, as Vermont has become the last holdout to change its rules.
More than two-thirds of the nation's new prescriptions in 2014 were transmitted electronically over the wires of Surescripts, the healthcare connectivity network announced Tuesday. In all, Surescrips processed 6.5 billion healthcare data transactions last year, more than the 6 billion processed by American Express and the 4.5 billion carried over the PayPal network.